Boditech Med

바디텍메드 · 206640

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$165.4M (₩228.3B)

Overview

Boditech Med makes rapid diagnostic test cartridges and the handheld reader devices that run them, allowing clinicians to test for infections, cardiovascular conditions, hormonal disorders, cancer markers, and other diseases at the point of care rather than sending samples to a central lab.

Its products are used by hospitals, clinics, and other health-care providers, and it ships to over a hundred countries worldwide. Listed on KOSDAQ, Korea's tech-focused small-cap exchange, the company operates two distinct business lines: the single-use test cartridges and the diagnostic reader instruments that process them.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$117.5M
▲ +17.3% YoY
Operating profit · FY2025
US$21M
▲ +10.7% YoY
Net income · FY2025
US$17.3M
▼ −12.3% YoY

Revenue

  • FY2023US$97.3M
  • FY2024US$100.1M
  • FY2025US$117.5M

Operating profit

  • FY2023US$20.6M
  • FY2024US$18.9M
  • FY2025US$21M

Net income

  • FY2023US$19.3M
  • FY2024US$19.7M
  • FY2025US$17.3M

Key ratios (FY2025)

ROE
9.8%
Debt/Eq
15.3%
Op. margin
17.9%
Net margin
14.7%
Rev. YoY
▲ +17.3%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.